ELIZABETH GALLER: Open Payments
NPI 1629439302 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,937 in 117 payments from 18 companies in 2025. Trend: 2023 $2,133 · 2024 $1,765 · 2025 $1,937
Food & beverage: $1,937
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $273 |
| ABBVIE INC. | 17 | $234 |
| Arcutis Biotherapeutics, Inc. | 7 | $148 |
| UCB, Inc. | 7 | $143 |
| E.R. Squibb & Sons, L.L.C. | 18 | $140 |
| Organon LLC | 21 | $117 |
| PFIZER INC. | 5 | $109 |
| Lilly USA, LLC | 4 | $103 |
| LEO Pharma Inc. | 3 | $100 |
| Incyte Corporation | 4 | $93 |
Products named: TREMFYA, Zoryve, Bimzelx, Sotyktu, SKYRIZI, CIBINQO, RINVOQ, VTAMA.
Industry payments across MO — which companies pay providers there.
